Al Shroouk Scan & Lab launches US$20M healthcare expansion in Egypt

The expansion strategy also includes growing the group’s radiotherapy and advanced imaging services as demand for specialised healthcare rises across Egypt.

EGYPT—Egyptian diagnostics provider Al Shroouk Scan & Lab is preparing a major expansion drive valued at US$20 million as it seeks to strengthen its presence across Cairo and several governorates over the next four years.

Chairperson and Managing Director Abdallah Mostafa said the company plans to open new branches in Cairo’s Fifth Settlement, Alexandria, Menoufia, and Gharbia, with the rollout expected to continue through 2030.

The expansion strategy also includes growing the group’s radiotherapy and advanced imaging services as demand for specialised healthcare rises across Egypt.

Founded in 2009, Al Shroouk Scan & Lab opened its first branch in Talbiya, Giza, in 2010 before gradually expanding into Faisal, Plaza Doctors Tower, El Manial, Sharkia Street, El Khosous, and 6th of October City.

The company was formally restructured in 2014 with a capital base of EGP 3.2 million (US$61,195).

That same year, Bedaya Fund for Financing Small and Medium Enterprises acquired a 33% stake in the company, helping support the launch of its 6th of October branch.

The facility was built on a 1,000-square-metre site for EGP8 million (US$152,987), covering construction and medical equipment investments.

New radiotherapy facilities planned

As part of the latest expansion phase, the group intends to establish a new branch at Palm Hills’ Strada Rise development, with an estimated investment of US$8 million.

The facility will include specialised radiation therapy services supported by medical systems valued at nearly US$3 million.

Construction plans also feature radiation-shielded concrete treatment rooms and upgraded healthcare infrastructure.

In addition, the company plans to develop another radiotherapy centre in the R3 district of Egypt’s New Administrative Capital on a 3,000-square-metre site.

Mostafa said the company expects annual revenues to rise by up to 200% once the radiotherapy services become operational.

Financing and technology Investments

Al Shroouk Scan & Lab has secured nearly US$9 million in financing over the years to support equipment purchases and branch development.

In 2018, the company obtained EGP70 million (US$1.34 million) from SAIB Bank under Egypt’s SME financing initiative.

Additional funding included EGP8 million (US$152,987) from Nile Leasing, EGP48 million (US$917,405) from the National Bank of Egypt, and EGP35 million (US$669,221) from Plus Leasing.

The company has invested heavily in diagnostic technology supplied by GE Healthcare, including a closed MRI system valued at US$1.75 million and an open MRI system valued at US$500,000.

Mostafa said that company revenues have risen from EGP1 million (US$19,123) in 2009 to nearly EGP140 million (US$2.7 million) today, while total investments have reached approximately EGP1 billion (US$19 million).

The group currently operates five branches and employs around 400 staff members trained in modern healthcare service standards.

It also maintains contracts with Cleopatra Hospital Group and several professional syndicates.

Al Shroouk Scan & Lab has also received certification from the Global Clinical Institute (GCI) for compliance with international laboratory and radiology quality standards.

Mostafa added that the company plans to list on the Egyptian Exchange once its branch network expands to eight locations.

 

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Visited 42 times, 8 visit(s) today

Newer Post

Thumbnail for Al Shroouk Scan & Lab launches US$20M healthcare expansion in Egypt

Metabolic collaborates with Roche to establish early Alzheimer’s screening research initiative in Dubai

Older Post

Thumbnail for Al Shroouk Scan & Lab launches US$20M healthcare expansion in Egypt

African leaders mobilizes regional response to Bundibugyo Ebola outbreak

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *